Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Inovalon (INOV) Competitors

Inovalon logo

INOV vs. QXO, YY, BCOV, ADEX, LTRPA, LIFW, LYT, NHIQ, NH, and WEJOF

Should you be buying Inovalon stock or one of its competitors? The main competitors of Inovalon include QXO (QXO), JOYY (YY), Brightcove (BCOV), Adit EdTech Acquisition (ADEX), Liberty TripAdvisor (LTRPA), MSP Recovery (LIFW), Lytus Technologies Holdings PTV. (LYT), NantHealth (NHIQ), NantHealth (NH), and Wejo Group (WEJOF).

Inovalon vs. Its Competitors

Inovalon (NASDAQ:INOV) and QXO (NASDAQ:QXO) are both data processing & preparation industry companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

In the previous week, QXO had 14 more articles in the media than Inovalon. MarketBeat recorded 14 mentions for QXO and 0 mentions for Inovalon. QXO's average media sentiment score of 0.95 beat Inovalon's score of 0.00 indicating that QXO is being referred to more favorably in the news media.

Company Overall Sentiment
Inovalon Neutral
QXO Positive

QXO has a net margin of 30.08% compared to Inovalon's net margin of 6.73%. Inovalon's return on equity of 10.97% beat QXO's return on equity.

Company Net Margins Return on Equity Return on Assets
Inovalon6.73% 10.97% 4.10%
QXO 30.08%1.58%1.30%

33.2% of Inovalon shares are held by institutional investors. Comparatively, 58.7% of QXO shares are held by institutional investors. 49.8% of Inovalon shares are held by company insiders. Comparatively, 51.3% of QXO shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

QXO has a consensus price target of $33.25, suggesting a potential upside of 53.23%. Given QXO's stronger consensus rating and higher probable upside, analysts clearly believe QXO is more favorable than Inovalon.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inovalon
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
QXO
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17

Inovalon has higher revenue and earnings than QXO. QXO is trading at a lower price-to-earnings ratio than Inovalon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inovalon$667.52M7.47$22.58M$0.3494.44
QXO$55.95M225.14-$1.07M-$10.05-2.16

Inovalon has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500. Comparatively, QXO has a beta of 2.41, meaning that its stock price is 141% more volatile than the S&P 500.

Summary

QXO beats Inovalon on 11 of the 17 factors compared between the two stocks.

Get Inovalon News Delivered to You Automatically

Sign up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INOV vs. The Competition

MetricInovalonData Processing & Preparation IndustryComputer SectorNASDAQ Exchange
Market Cap$4.98B$1.12B$27.79B$9.02B
Dividend YieldN/A6.01%3.13%4.08%
P/E Ratio94.444.7936.8820.04
Price / Sales7.4719.111,970.43100.83
Price / Cash33.3563.2134.7728.59
Price / Book6.500.977.245.55
Net Income$22.58M-$37.11M$763.56M$248.49M

Inovalon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INOV
Inovalon
N/A$32.11
-0.4%
N/A+12.3%$4.98B$667.52M94.441,836
QXO
QXO
3.6525 of 5 stars
$21.54
+3.9%
$34.33
+59.4%
N/A$12.46B$55.95M-2.36195High Trading Volume
YY
JOYY
1.9592 of 5 stars
$50.90
+0.6%
$35.00
-31.2%
+57.0%$2.74B$2.24B15.387,450Positive News
BCOV
Brightcove
0.5301 of 5 stars
$4.45
flat
$3.98
-10.7%
N/A$202.12M$201.19M-21.19720
ADEX
Adit EdTech Acquisition
N/A$5.38
flat
N/AN/A$47.88M$19.62M0.007
LTRPA
Liberty TripAdvisor
N/A$0.26
flat
N/AN/A$20.29M$1.68B-0.113,100
LIFW
MSP Recovery
N/A$1.21
-4.0%
N/A-89.9%$7.94M$10.73M-0.013Positive News
LYT
Lytus Technologies Holdings PTV.
N/A$0.07
-40.6%
N/A-96.7%$2.18M$23.72M0.003Gap Down
High Trading Volume
NHIQ
NantHealth
N/A$0.01
+10.0%
N/AN/A$359K$67M0.00340
NH
NantHealth
N/A$0.01
+10.0%
N/AN/A$85K$67.68M0.00340
WEJOF
Wejo Group
N/A$0.00
flat
N/AN/A$11K$8.40M0.00300

Related Companies and Tools


This page (NASDAQ:INOV) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners